Matches in Nanopublications for { ?s ?p "[Our results provide first in vivo evidence for the molecular targeting therapeutic application of the K-ras repressor ESX1, especially TAT-mediated transduction of N-ESX1, in the treatment of human cancers having oncogenic K-ras mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP651195.RAdpX9i-gblQ2V9ninFjkMBZDWe6Tb2aCyGxkwl_uQ7oA130_assertion description "[Our results provide first in vivo evidence for the molecular targeting therapeutic application of the K-ras repressor ESX1, especially TAT-mediated transduction of N-ESX1, in the treatment of human cancers having oncogenic K-ras mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651195.RAdpX9i-gblQ2V9ninFjkMBZDWe6Tb2aCyGxkwl_uQ7oA130_provenance.
- NP932903.RASJSets9wAnSqFhGe_GHQ98l11AzDbeMsBvcHuujMZ28130_assertion description "[Our results provide first in vivo evidence for the molecular targeting therapeutic application of the K-ras repressor ESX1, especially TAT-mediated transduction of N-ESX1, in the treatment of human cancers having oncogenic K-ras mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP932903.RASJSets9wAnSqFhGe_GHQ98l11AzDbeMsBvcHuujMZ28130_provenance.
- NP623081.RAFYgeCzU3XMRQhxT5uGdYBPQjAlLwHiyRBwVQ6wdqnIc130_assertion description "[Our results provide first in vivo evidence for the molecular targeting therapeutic application of the K-ras repressor ESX1, especially TAT-mediated transduction of N-ESX1, in the treatment of human cancers having oncogenic K-ras mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623081.RAFYgeCzU3XMRQhxT5uGdYBPQjAlLwHiyRBwVQ6wdqnIc130_provenance.